At the recent American Society of Hematology annual meeting, researchers presented real-world outcomes for patients with ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...

Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorablesafety ...

Orca Bio presents positive new data from its pipeline of allogeneic T-cell immunotherapies at the 67th ASH Annual Meeting.

Lisaftoclax monotherapy demonstrated significant and durable clinical efficacy and a manageable safety profile in patients ...

The US Acute Myeloid Leukemia Market is poised for continued growth, expected to show a CAGR of $% from 2022 to 2028. The future outlook is characterized by: The ongoing development of targeted ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

ePediatric Endocrinology, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany Tyrosine kinase ...

Ascentage Pharma Group International Unsponsored ADR ( ($AAPG) ) has issued an update. On November 24, 2025, Ascentage Pharma announced the ...

Kisqali NATALEE and MONALEESA data add to evidence of long-term benefits for early and metastatic breast cancer patients ...